These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1077 related articles for article (PubMed ID: 25434381)
1. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381 [TBL] [Abstract][Full Text] [Related]
2. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Golden EB; Cho HY; Hofman FM; Louie SG; Schönthal AH; Chen TC Neurosurg Focus; 2015 Mar; 38(3):E12. PubMed ID: 25727221 [TBL] [Abstract][Full Text] [Related]
3. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. Lee SW; Kim HK; Lee NH; Yi HY; Kim HS; Hong SH; Hong YK; Joe YA Cancer Lett; 2015 May; 360(2):195-204. PubMed ID: 25681668 [TBL] [Abstract][Full Text] [Related]
4. Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells. Hori YS; Hosoda R; Akiyama Y; Sebori R; Wanibuchi M; Mikami T; Sugino T; Suzuki K; Maruyama M; Tsukamoto M; Mikuni N; Horio Y; Kuno A J Neurooncol; 2015 Mar; 122(1):11-20. PubMed ID: 25528635 [TBL] [Abstract][Full Text] [Related]
5. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911 [TBL] [Abstract][Full Text] [Related]
6. Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts. Gupta SK; Mladek AC; Carlson BL; Boakye-Agyeman F; Bakken KK; Kizilbash SH; Schroeder MA; Reid J; Sarkaria JN Clin Cancer Res; 2014 Jul; 20(14):3730-41. PubMed ID: 24838527 [TBL] [Abstract][Full Text] [Related]
7. Impact of autophagy inhibition at different stages on cytotoxic effect of autophagy inducer in glioblastoma cells. Li C; Liu Y; Liu H; Zhang W; Shen C; Cho K; Chen X; Peng F; Bi Y; Hou X; Yang Z; Zheng Z; Wang K; Wang X; Zhang J; Zhong C; Zou H; Zhang X; Zhao S Cell Physiol Biochem; 2015; 35(4):1303-16. PubMed ID: 25721868 [TBL] [Abstract][Full Text] [Related]
8. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746 [TBL] [Abstract][Full Text] [Related]
9. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas. Gonçalves RM; Agnes JP; Delgobo M; de Souza PO; Thomé MP; Heimfarth L; Lenz G; Moreira JCF; Zanotto-Filho A Biochem Pharmacol; 2019 May; 163():440-450. PubMed ID: 30878553 [TBL] [Abstract][Full Text] [Related]
10. Autophagy inhibition potentiates SAHA‑mediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria. Lohitesh K; Saini H; Srivastava A; Mukherjee S; Roy A; Chowdhury R Oncol Rep; 2018 Jun; 39(6):2787-2796. PubMed ID: 29658588 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224 [TBL] [Abstract][Full Text] [Related]
12. Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro. Ryabaya OO; Inshakov AN; Egorova AV; Emelyanova MA; Nasedkina TV; Zasedatelev AS; Khochenkov DA; Stepanova EV Anticancer Drugs; 2017 Mar; 28(3):307-315. PubMed ID: 27941537 [TBL] [Abstract][Full Text] [Related]
13. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition. Zhang P; Sun S; Li N; Ho ASW; Kiang KMY; Zhang X; Cheng YS; Poon MW; Lee D; Pu JKS; Leung GKK J Neurooncol; 2017 May; 132(3):393-400. PubMed ID: 28293765 [TBL] [Abstract][Full Text] [Related]
14. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity. Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595 [TBL] [Abstract][Full Text] [Related]
15. Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems. Toren A; Pismenyuk T; Yalon M; Freedman S; Simon AJ; Fisher T; Moshe I; Reichardt JK; Constantini S; Mardor Y; Last D; Guez D; Daniels D; Assoulin M; Mehrian-Shai R Oncotarget; 2016 Nov; 7(46):74860-74871. PubMed ID: 27556862 [TBL] [Abstract][Full Text] [Related]
16. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death. Cheng Y; Sk UH; Zhang Y; Ren X; Zhang L; Huber-Keener KJ; Sun YW; Liao J; Amin S; Sharma AK; Yang JM PLoS One; 2012; 7(4):e35104. PubMed ID: 22496897 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy. Wang J; Qi Q; Zhou W; Feng Z; Huang B; Chen A; Zhang D; Li W; Zhang Q; Jiang Z; Bjerkvig R; Prestegarden L; Thorsen F; Wang X; Li X; Wang J Autophagy; 2018; 14(11):2007-2022. PubMed ID: 30025493 [TBL] [Abstract][Full Text] [Related]
18. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways. Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789 [TBL] [Abstract][Full Text] [Related]